CVS, Aetna expect their roughly $69 billion deal to close within days

• CVS Health and Aetna have received the final state approval they need to complete their roughly $69 billion merger.

• CVS and Aetna expect the deal to close "on or about" Nov. 28, the companies said Monday in regulatory filings.

• The Department of Justice granted preliminary approval in October on the condition that CVS and Aetna removed overlap between their Medicare Part D plans.

CVS Health CVS and Aetna AET have received the final state approval they need to complete their roughly $69 billion merger and now expect the deal to close "on or about" Nov. 28, the companies said Monday in regulatory filings.

The companies had been expecting to finalize the merger by Thanksgiving. However, a handful of the 28 states CVS and Aetna needed approval from opposed the combination, saying it would reduce competition and could leave consumers worse off.

CVS and Aetna announced the deal last December. The Department of Justice granted preliminary approval in October on the condition that CVS and Aetna removed overlap between their Medicare Part D plans. Aetna said it would sell its Medicare Part D drug plan business to WellCare Health Plans WCG for an undisclosed amount to ease the concerns.

More From CNBC

• Novartis CEO: Four factors can help to price lifesaving cell and gene therapies
  

• FDA to overhaul more than 40-year-old process for approving medical devices
  

• 3 sectors that offer solid returns as the bull market loses steam